Your browser doesn't support javascript.
loading
RUNX3 and CAMK2N1 hypermethylation as prognostic marker for epithelial ovarian cancer.
Häfner, Norman; Steinbach, Daniel; Jansen, Lars; Diebolder, Herbert; Dürst, Matthias; Runnebaum, Ingo B.
Afiliação
  • Häfner N; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
  • Steinbach D; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
  • Jansen L; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
  • Diebolder H; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
  • Dürst M; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
  • Runnebaum IB; Department of Gynecology, Jena University Hospital-Friedrich Schiller University, Jena, Germany.
Int J Cancer ; 138(1): 217-28, 2016 Jan 01.
Article em En | MEDLINE | ID: mdl-26175272

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteínas / Neoplasias Epiteliais e Glandulares / Metilação de DNA / Subunidade alfa 3 de Fator de Ligação ao Core Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteínas / Neoplasias Epiteliais e Glandulares / Metilação de DNA / Subunidade alfa 3 de Fator de Ligação ao Core Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article